Description
Montelukast-Teva (montelukast sodium) Chewing Tablets 4 mg.
Montelukast-Teva is a medication that contains the active ingredient montelukast sodium in the form of chewable tablets with a strength of 4 mg. per tablet. It is available in a pack size of 28 tablets and is commonly used to treat various respiratory conditions such as asthma and allergic rhinitis. Montelukast-Teva belongs to a class of medications known as leukotriene receptor antagonists, which work by blocking the action of certain substances in the body that cause inflammation and constriction of the airways.
Indications
Montelukast-Teva is indicated for the treatment of:
- Asthma in adults and children aged 2 to 14 years
- Prevention of exercise-induced bronchoconstriction in patients aged 6 years and older
- Seasonal allergic rhinitis in patients aged 2 years and older
- Perennial allergic rhinitis in patients aged 6 months and older
How It Works
Montelukast-Teva works by selectively blocking the action of leukotrienes, which are inflammatory mediators involved in the pathophysiology of asthma and allergic rhinitis. By inhibiting the activity of leukotrienes, Montelukast-Teva helps to reduce inflammation, bronchoconstriction, and other symptoms associated with these conditions, thus improving breathing and overall respiratory function.
Administration
Montelukast-Teva chewable tablets are designed to be chewed or dissolved in the mouth before swallowing. They can be taken with or without food. The recommended dosage and frequency of administration will vary depending on the specific condition being treated and the age of the patient. It is important to follow the instructions provided by your healthcare provider or pharmacist when taking Montelukast-Teva to ensure optimal therapeutic outcomes.
Side Effects
Like all medications, Montelukast-Teva may cause side effects in some individuals. Common side effects may include:
- Headache
- Abdominal pain
- Diarrhea
- Flu-like symptoms
- Cough
If you experience any persistent or severe side effects while taking Montelukast-Teva, it is important to contact your healthcare provider immediately. In rare cases, this medication may cause serious allergic reactions or neuropsychiatric events. Seek medical attention if you develop symptoms such as rash, swelling, difficulty breathing, or changes in mood or behavior.
Precautions
Before taking Montelukast-Teva, inform your healthcare provider if you have any allergies, medical conditions, or are taking any other medications, including over-the-counter drugs and supplements. It is important to disclose this information to avoid potential drug interactions and adverse effects.
Montelukast-Teva should be used with caution in patients with a history of certain medical conditions, such as liver disease or phenylketonuria. It is not recommended for use in patients with a known hypersensitivity to montelukast sodium or any other components of the formulation.
Storage
Montelukast-Teva chewable tablets should be stored at room temperature (between 20°C and 25°C) in a dry place away from direct sunlight and moisture. Keep the tablets in their original packaging and out of reach of children and pets. Do not use Montelukast-Teva past the expiration date printed on the packaging.
Conclusion
Montelukast-Teva is a widely used medication for the management of asthma and allergic rhinitis in both children and adults. By inhibiting the activity of leukotrienes, Montelukast-Teva helps to reduce inflammation and improve respiratory function, thereby providing relief from symptoms associated with these conditions. It is important to follow the recommended dosage and administration instructions when taking Montelukast-Teva and to report any side effects or concerns to your healthcare provider promptly. With proper use and monitoring, Montelukast-Teva can be an effective treatment option for individuals with asthma and allergic rhinitis.
